June 13, 2018 01:17 PM EDT
Deals

Buy­out buzz bumps Madri­gal stock fur­ther north, stok­ing the in­dus­try's NASH ob­ses­sion

Brittany Meiling

Just weeks af­ter the com­pa­ny’s promis­ing NASH da­ta rock­et­ed its stock near­ly 150%, Madri­gal is get­ting an­oth­er boost to its share price to­day on buzz …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times